Search - tctmd.com

Displaying 1 - 20 of 49

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Daily News

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Michael O'Riordan

April 17, 2024

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

Another Study Links Stopping Statins to MACE in the Elderly

Shelley Wood

December 03, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Conference News ESC 2021

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

Michael O'Riordan

August 27, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Daily News

Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes

Shelley Wood

April 13, 2021

News Daily News

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

Michael O'Riordan

February 19, 2021

News Daily News

CAC Testing Improves Pretest Probability of Obstructive CAD

Michael O'Riordan

November 23, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Daily News

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

Yael L. Maxwell

August 06, 2020

News Daily News

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Shelley Wood

February 28, 2020

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Conference News AHA 2017

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Yael L. Maxwell

November 14, 2017

Advertisement

What’s Going to Be Hot at TCT 2025

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

TCTMD’s Top 10 Most Popular Stories for February 2023

Another Study Links Stopping Statins to MACE in the Elderly

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Korean Registry Casts Fresh Light on Late STEMI Care, Outcomes

Smoking, Drinking, and Drugs—All Signs Point to Earlier ASCVD

CAC Testing Improves Pretest Probability of Obstructive CAD

TCTMD’s Top 10 Most Popular Stories for October 2020

Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement

New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib

Top News in Coronary Artery Disease: 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content